Tel Aviv - Delayed Quote ILA

InterCure Ltd. (INCR.TA)

999.90 +7.60 (+0.77%)
At close: April 25 at 2:24 PM GMT+3
Currency in ILS All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
414,792.00
388,684.00
219,677.00
65,035.00
Cost of Revenue
275,751.00
233,601.00
128,546.00
33,060.00
Gross Profit
139,041.00
155,083.00
91,131.00
31,975.00
Operating Expense
122,304.00
113,883.00
58,107.00
28,617.00
Operating Income
16,737.00
41,200.00
33,024.00
3,358.00
Net Non Operating Interest Income Expense
-26,407.00
-14,111.00
-4,915.00
-507.00
Other Income Expense
15,069.00
16,753.00
-9,375.00
-41,159.00
Pretax Income
5,399.00
43,842.00
18,734.00
-38,308.00
Tax Provision
-11,992.00
93.00
11,441.00
-2,268.00
Net Income Common Stockholders
20,904.00
44,819.00
4,690.00
-37,231.00
Diluted NI Available to Com Stockholders
20,904.00
44,819.00
4,690.00
-37,231.00
Basic EPS
0.46
0.99
0.12
-1.42
Diluted EPS
0.46
0.99
0.10
-1.42
Basic Average Shares
45,855.16
45,352.60
38,492.60
25,396.31
Diluted Average Shares
45,855.16
45,352.60
46,920.00
25,396.31
Total Operating Income as Reported
24,480.00
50,627.00
28,185.00
-38,400.00
Rent Expense Supplemental
--
5,997.00
2,837.00
395.00
Total Expenses
398,055.00
347,484.00
186,653.00
61,677.00
Net Income from Continuing & Discontinued Operation
20,904.00
44,819.00
4,690.00
-37,231.00
Normalized Income
15,311.49
37,682.17
9,621.08
-2,801.64
Interest Income
-5,709.00
844.00
130.00
21.00
Interest Expense
20,432.00
14,689.00
5,045.00
528.00
Net Interest Income
-26,407.00
-14,111.00
-4,915.00
-507.00
EBIT
25,831.00
58,531.00
23,779.00
-37,780.00
EBITDA
25,831.00
70,230.00
31,172.00
-34,527.00
Reconciled Cost of Revenue
275,751.00
226,126.00
124,084.00
30,498.00
Reconciled Depreciation
10,556.00
11,699.00
7,393.00
3,253.00
Net Income from Continuing Operation Net Minority Interest
20,904.00
44,819.00
4,690.00
-37,231.00
Total Unusual Items Excluding Goodwill
7,263.00
7,152.00
-6,404.00
-36,596.00
Total Unusual Items
7,263.00
7,152.00
-6,404.00
-36,596.00
Normalized EBITDA
18,568.00
63,078.00
37,576.00
2,069.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
1,670.49
15.17
-1,472.92
-2,166.64
12/31/2020 - 9/9/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TGTR.TA Together Pharma Ltd
484.00
-2.00%
 
CNZN.TA Canzon Israel Ltd
152.00
+0.07%
 
PNAX.TA Panaxia Labs Israel Ltd
9,800.00
+27.65%
 
TEVA.TA Teva Pharmaceutical Industries Limited
4,933.00
+0.98%
 
VRNOF Verano Holdings Corp.
4.6989
-9.64%
 
CRON.TO Cronos Group Inc.
3.4400
+0.88%
 
OGI.TO Organigram Holdings Inc.
2.5600
-3.76%
 
GTBIF Green Thumb Industries Inc.
11.80
-5.60%
 
TEVA Teva Pharmaceutical Industries Limited
13.25
+1.84%
 
WEED.TO Canopy Growth Corporation
11.86
-3.34%